Figure 3B provides quantification of the data obtained from microPET/CT scan of multiple animals showing almost 90% reduction in renal and salivary uptake with [68 Ga]Ga-PSMA-1-DOTA compared to [68 Ga]Ga-PSMA-11 but only approximately 50% reduction in tumor uptake at 1 h post-injection. This evidence concerns the gene FOLH1 and neoplasm.